IL22 and neoplasm: Although the role of IL-22 in cancer has not been well-elucidated and it is controversial, it has been described that it has a positive prognosis in this type of cancer, relying on its capacity to induce a cross-talk between tumor cells and immune cells associated with a favorable clinical outcome [67].